로딩 중…
StockDiggingStockDigging

SANIGEN

188260· KOSDAQ
₩2,060-1.67%
2026-09-18

Financials

Valuation Metrics

SANIGEN's Market Cap is ₩286B. At end of 2025 it was ₩267B. Ranked #2118 of 2,421 in KR market (top 87%), #1362 of 1,640 on KOSDAQ (top 83%), #86 of 96 in Health Care Equipment & Services (top 90%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap28.64B KRW
Revenue6.23B KRW
Net Income-5.15B KRW
Total Assets23.31B KRW
Net Assets11.42B KRW
Employees90
Value
P/B2.51x
P/S4.59x
Profitability
ROE-45.06%
ROA-22.08%
Op. Margin-63.68%
Revenue Growth-70.67%
Financial Health
Debt Ratio104.08%
Total Debt2.27B KRW
Cash6.36B KRW
Current Ratio2.35x
Performance
1Y Return-15.05%
1M Return4.04%
From 52W High-28.72%
1Y MDD-40.99%
Trading
Volume4,623 shares
Trading Value9.4M KRW
Foreign Own.0.45%
Per Share
EPS-370 KRW
BPS822 KRW

Company Info

CEO 박정웅
Employees 90
Founded 2005
HQ 경기도 안양시, KR
Website sanigen.kr

The company, Senygen, established in 2005 and listed on KOSDAQ in 2023, is a specialized total solution company for food safety. It manufactures and sells PCR and NGS-based food safety diagnostic products, and provides food microbial genome analysis services. The company offers core product lines such as Genelix, GeNext, and Geneka, alongside sterilization products. Senygen is enhancing its existing product performance and expanding its business into non-food diagnostics industries, leveraging its microbial analysis technology. Senygen was established in 2005 and is headquartered in Anyang-si, Gyeonggi-do.